| WST |
Report |
Q2 revenue |
IN-LINE |
pred ~$834M vs. cons $841M |
MEDIUM |
| WST |
Report |
Q2 adjusted diluted EPS |
MISS |
pred ~$2.04 vs. cons $2.09 |
MEDIUM |
| WST |
Report |
Q2 adjusted operating margin |
MISS |
pred ~20.7% vs. cons 21.4% |
MEDIUM |
| WST |
Guide |
Revenue guidance |
LOWER |
guide ~$3.31B vs. cons $3.34B (FY2026) |
MEDIUM |
| WST |
Guide |
Adjusted diluted EPS guidance |
LOWER |
guide ~$8.50 vs. cons $8.68 (FY2026) |
MEDIUM |
| WST |
Guide |
Revenue guidance |
LOWER |
guide ~$800M vs. cons $818M (Q3 2026) |
LOW |
| WST |
Guide |
Adjusted diluted EPS guidance |
LOWER |
guide ~$2.08 vs. cons $2.19 (Q3 2026) |
LOW |
| WST |
Return |
Day-1 residual (stock − beta × S&P 500) |
-7.5% |
— |
MEDIUM |
| WST |
Return |
5-day cumulative residual |
-9.5% (FOLLOW-THROUGH) |
FY2026 adjusted EPS guidance of ~$8.50 vs. consensus $8.68 and Q3 adjusted EPS guidance of ~$2.08 vs. consensus $2.19 imply downward revisions after a Q2 miss, sustaining pressure beyond day 1. |
MEDIUM |